Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
14 November 2018Website:
http://www.vapotherm.comNext earnings report:
08 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Thu, 19 Sep 2024 19:20:44 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
VAPO Latest News
EXETER, N.H. , Sept. 20, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), announced today that it has closed its merger with a newly-formed entity organized and funded by an affiliate of Perceptive Advisors, LLC.
EXETER, N.H. , Aug. 12, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), today announced second quarter 2024 financial results and related highlights.
NEW YORK , July 9, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Vapotherm, Inc. (OTCQX: VAPO), relating to its proposed merger with an affiliate of Perceptive Advisors, LLC.
NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Vapotherm , Inc . ( OTCQX: VAPO ), relating to its proposed merger with an affiliate of Perceptive Advisors, LLC. Under the terms of the agreement, Vapotherm shareholders will receive $2.18 in cash for each share of Vapotherm common stock they own.
LOS ANGELES, CA / ACCESSWIRE / July 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Vapotherm, Inc. ("Vapotherm" or "the Company") (OTCQX:VAPO) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Vapotherm board breached its fiduciary duties to shareholders.
- 1(current)
What type of business is Vapotherm?
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
What sector is Vapotherm in?
Vapotherm is in the Healthcare sector
What industry is Vapotherm in?
Vapotherm is in the Medical Devices industry
What country is Vapotherm from?
Vapotherm is headquartered in United States
When did Vapotherm go public?
Vapotherm initial public offering (IPO) was on 14 November 2018
What is Vapotherm website?
https://www.vapotherm.com
Is Vapotherm in the S&P 500?
No, Vapotherm is not included in the S&P 500 index
Is Vapotherm in the NASDAQ 100?
No, Vapotherm is not included in the NASDAQ 100 index
Is Vapotherm in the Dow Jones?
No, Vapotherm is not included in the Dow Jones index
When was Vapotherm the previous earnings report?
No data
When does Vapotherm earnings report?
The next expected earnings date for Vapotherm is 08 November 2024